Bioadaptives, INC Form 4 insider transactions
Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.
OID
Mark P Frissora, a Director of Bioadaptives, Inc., reported a transaction in 15,152 shares of common stock on 2026-08-01-05:00.
OID
Bioadaptives, Inc. reports that Director Mark P. Frissora received Series D Convertible Preferred Stock as compensation for board services.
OID
Director Mark P. Frissora acquired 4,717 shares of Series D Convertible Preferred Stock as compensation for board services.
OID
Bioadaptives, Inc. reports that Director Mark P. Frissora received Series D Convertible Preferred Stock as compensation for board services.
OID
Bioadaptives, Inc. director Mark P. Frissora received Series D Convertible Preferred Stock as compensation for board services.
OID
Bioadaptives Director Mark P. Frissora acquired 2,578 shares of Series D Convertible Preferred Stock as compensation for board services.
OID
BIOADAPTIVES, INC. Director Mark P. Frissora received 2,565 shares of Series D Convertible Preferred Stock as compensation for board services.
OID
Bioadaptives Director Mark P. Frissora acquired Series D Convertible Preferred Stock as compensation for board services, increasing his beneficial ownership.
OID
BIOADAPTIVES, INC. director Mark P. Frissora received 2,025 shares of Series D Convertible Preferred Stock as compensation for board services.
OID
BIOADAPTIVES, Inc. Director Mark P. Frissora was granted 1,382 shares of Series D Convertible Preferred Stock as compensation for board services.
OID
BioAdaptives, Inc. director Mark P. Frissora received 1,517 shares of Series D Convertible Preferred Stock as compensation for board services.
OID
Mark P. Frissora, a director at Bioadaptives, Inc., was granted 1,506 shares of Series D Convertible Preferred Stock as compensation for board services.
OID
BIOADAPTIVES Director Mark P. Frissora acquired 1,307 shares of Series D Convertible Preferred Stock as compensation for board services.
OID
Form 4: Bioadaptives Director Mark Frissora Receives Significant Convertible Preferred Stock as Compensation
Bioadaptives, Inc. Director Mark P. Frissora was issued 847 shares of Series D Convertible Preferred Stock as compensation for board services, convertible into 84,700 shares of common stock.
OID
Form 4: BIOADAPTIVES Director Mark Frissora Receives Convertible Preferred Stock as Board Compensation
BIOADAPTIVES, Inc. Director Mark P. Frissora was granted 713 shares of Series D Convertible Preferred Stock as compensation for board services, convertible into common stock at a 100:1 ratio.
OID
BIOADAPTIVES, Inc. Director Mark P. Frissora was granted 694 shares of Series D Convertible Preferred Stock as compensation for board services, convertible into common stock at a 100:1 ratio.
OID
Director Mark P. Frissora reports acquiring Series D Convertible Preferred Stock and an option to purchase common stock in Bioadaptives, Inc.
OID
A BioAdaptives director, Gimhana Sasanka Dissanayake, acquired 125,000 shares of common stock at $0.085 per share on November 22, 2024.